• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

P2Y1受体激动剂减弱转化生长因子-β1触发的心脏成纤维细胞激活。

P2Y1 Receptor Agonist Attenuates Cardiac Fibroblasts Activation Triggered by TGF-β1.

作者信息

Tian Geer, Zhou Junteng, Quan Yue, Kong Qihang, Wu Wenchao, Liu Xiaojing

机构信息

Laboratory of Cardiovascular Diseases, Regenerative Medicine Research Center, West China Hospital, Sichuan University, Chengdu, China.

Department of Cardiology, West China Hospital, Sichuan University, Chengdu, China.

出版信息

Front Pharmacol. 2021 Feb 17;12:627773. doi: 10.3389/fphar.2021.627773. eCollection 2021.

DOI:10.3389/fphar.2021.627773
PMID:33679406
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7926204/
Abstract

Cardiac fibroblasts (CFs) activation is a hallmark feature of cardiac fibrosis caused by cardiac remodeling. The purinergic signaling molecules have been proven to participate in the activation of CFs. In this study, we explored the expression pattern of P2Y receptor family in the cardiac fibrosis mice model induced by the transverse aortic constriction (TAC) operation and in the activation of CFs triggered by transforming growth factor β1 (TGF-β1) stimulation. We then investigated the role of P2Y1receptor (P2Y1R) in activated CFs. The results showed that among P2Y family members, only P2Y1R was downregulated in the heart tissues of TAC mice. Consistent with our results, the level of P2Y1R was decreased in the activated CFs, when CFs were treated with TGF-β1. Silencing P2Y1R expression with siP2Y1R accelerated the effects of TGF-β1 on CFs activation. Moreover, the P2Y1R selective antagonist BPTU increased the levels of mRNA and protein of profibrogenic markers, such as connective tissue growth factor (CTGF), periostin (POSTN). periostin (POSTN), and α-smooth muscle actin(α-SMA). Further, MRS2365, the agonist of P2Y1R, ameliorated the activation of CFs and activated the p38 MAPK and ERK signaling pathways. In conclusion , our findings revealed that upregulating of P2Y1R may attenuate the abnormal activation of CFs via the p38 MAPK and ERK signaling pathway.

摘要

心脏成纤维细胞(CFs)的激活是心脏重塑所致心脏纤维化的一个标志性特征。嘌呤能信号分子已被证明参与CFs的激活。在本研究中,我们探究了P2Y受体家族在经主动脉缩窄(TAC)手术诱导的心脏纤维化小鼠模型中以及在转化生长因子β1(TGF-β1)刺激引发的CFs激活中的表达模式。然后,我们研究了P2Y1受体(P2Y1R)在激活的CFs中的作用。结果显示,在P2Y家族成员中,只有P2Y1R在TAC小鼠的心脏组织中表达下调。与我们的结果一致,当用TGF-β1处理CFs时,激活的CFs中P2Y1R的水平降低。用siP2Y1R沉默P2Y1R表达加速了TGF-β1对CFs激活的作用。此外,P2Y1R选择性拮抗剂BPTU增加了促纤维化标志物的mRNA和蛋白质水平,如结缔组织生长因子(CTGF)、骨膜蛋白(POSTN)、骨膜蛋白(POSTN)和α平滑肌肌动蛋白(α-SMA)。此外,P2Y1R激动剂MRS2365改善了CFs的激活,并激活了p38丝裂原活化蛋白激酶(MAPK)和细胞外信号调节激酶(ERK)信号通路。总之,我们的研究结果表明,上调P2Y1R可能通过p38 MAPK和ERK信号通路减弱CFs的异常激活。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed19/7926204/bcd164d4894f/fphar-12-627773-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed19/7926204/597645fc0057/fphar-12-627773-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed19/7926204/beaa9de76599/fphar-12-627773-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed19/7926204/eaf4d7c40f9b/fphar-12-627773-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed19/7926204/bcd164d4894f/fphar-12-627773-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed19/7926204/597645fc0057/fphar-12-627773-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed19/7926204/beaa9de76599/fphar-12-627773-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed19/7926204/eaf4d7c40f9b/fphar-12-627773-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed19/7926204/bcd164d4894f/fphar-12-627773-g004.jpg

相似文献

1
P2Y1 Receptor Agonist Attenuates Cardiac Fibroblasts Activation Triggered by TGF-β1.P2Y1受体激动剂减弱转化生长因子-β1触发的心脏成纤维细胞激活。
Front Pharmacol. 2021 Feb 17;12:627773. doi: 10.3389/fphar.2021.627773. eCollection 2021.
2
Inhibition of P2X7 Purinergic Receptor Ameliorates Cardiac Fibrosis by Suppressing NLRP3/IL-1 Pathway.P2X7 嘌呤能受体抑制通过抑制 NLRP3/IL-1 通路减轻心脏纤维化。
Oxid Med Cell Longev. 2020 May 21;2020:7956274. doi: 10.1155/2020/7956274. eCollection 2020.
3
Stachydrine Ameliorates Cardiac Fibrosis Through Inhibition of Angiotensin II/Transformation Growth Factor β1 Fibrogenic Axis.水苏碱通过抑制血管紧张素II/转化生长因子β1纤维化轴改善心脏纤维化。
Front Pharmacol. 2019 May 22;10:538. doi: 10.3389/fphar.2019.00538. eCollection 2019.
4
Velvet antler peptide prevents pressure overload-induced cardiac fibrosis via transforming growth factor (TGF)-β1 pathway inhibition.鹿茸多肽通过抑制转化生长因子(TGF)-β1通路预防压力超负荷诱导的心脏纤维化。
Eur J Pharmacol. 2016 Jul 15;783:33-46. doi: 10.1016/j.ejphar.2016.04.039. Epub 2016 Apr 21.
5
SGK1 is necessary to FoxO3a negative regulation, oxidative stress and cardiac fibroblast activation induced by TGF-β1.SGK1 对于 TGF-β1 诱导的 FoxO3a 负调控、氧化应激和心肌成纤维细胞激活是必要的。
Cell Signal. 2023 Sep;109:110778. doi: 10.1016/j.cellsig.2023.110778. Epub 2023 Jun 19.
6
Curcumin suppresses transforming growth factor-β1-induced cardiac fibroblast differentiation via inhibition of Smad-2 and p38 MAPK signaling pathways.姜黄素通过抑制Smad-2和p38丝裂原活化蛋白激酶信号通路来抑制转化生长因子-β1诱导的心脏成纤维细胞分化。
Exp Ther Med. 2016 Mar;11(3):998-1004. doi: 10.3892/etm.2016.2969. Epub 2016 Jan 8.
7
Synthetic Prostacyclin Agonist Attenuates Pressure-Overloaded Cardiac Fibrosis by Inhibiting FMT.合成前列环素激动剂通过抑制FMT减轻压力超负荷引起的心脏纤维化。
Mol Ther Methods Clin Dev. 2020 Sep 16;19:210-219. doi: 10.1016/j.omtm.2020.09.005. eCollection 2020 Dec 11.
8
Acetazolamide attenuates cardiac fibrosis induced by aortic constriction through inhibiting transforming growth factor-β1/Smad2 signaling pathway in mice.乙酰唑胺通过抑制小鼠转化生长因子-β1/Smad2信号通路减轻主动脉缩窄诱导的心脏纤维化。
Exp Ther Med. 2019 Mar;17(3):2317-2321. doi: 10.3892/etm.2019.7210. Epub 2019 Jan 28.
9
Respective roles of the mitogen-activated protein kinase (MAPK) family members in pancreatic stellate cell activation induced by transforming growth factor-β1 (TGF-β1).丝裂原活化蛋白激酶(MAPK)家族成员在转化生长因子-β1(TGF-β1)诱导的胰腺星状细胞活化中的各自作用。
Biochem Biophys Res Commun. 2018 Jun 22;501(2):365-373. doi: 10.1016/j.bbrc.2018.04.176.
10
Angiotensin II increases periostin expression via Ras/p38 MAPK/CREB and ERK1/2/TGF-β1 pathways in cardiac fibroblasts.血管紧张素 II 通过 Ras/p38 MAPK/CREB 和 ERK1/2/TGF-β1 通路增加心肌成纤维细胞中骨膜蛋白的表达。
Cardiovasc Res. 2011 Jul 1;91(1):80-9. doi: 10.1093/cvr/cvr067. Epub 2011 Mar 2.

引用本文的文献

1
Inhibition of tartrate-resistant acid phosphatase 5 can prevent cardiac fibrosis after myocardial infarction.抑制耐酒石酸酸性磷酸酶 5 可以预防心肌梗死后的心脏纤维化。
Mol Med. 2024 Jun 15;30(1):89. doi: 10.1186/s10020-024-00856-1.
2
The Pleiotropic Role of Extracellular ATP in Myocardial Remodelling.细胞外 ATP 在心肌重构中的多效作用。
Molecules. 2023 Feb 23;28(5):2102. doi: 10.3390/molecules28052102.
3
The long noncoding RNA THBS1-AS1 promotes cardiac fibroblast activation in cardiac fibrosis by regulating TGFBR1.长链非编码 RNA THBS1-AS1 通过调节 TGFBR1 促进心脏成纤维细胞激活在心脏纤维化。

本文引用的文献

1
Peptide DR8 suppresses epithelial-to-mesenchymal transition via the TGF-β/MAPK signaling pathway in renal fibrosis.肽 DR8 通过 TGF-β/MAPK 信号通路抑制肾纤维化中的上皮间质转化。
Life Sci. 2020 Nov 15;261:118465. doi: 10.1016/j.lfs.2020.118465. Epub 2020 Sep 18.
2
Extracellular Nucleotides Selectively Induce Migration of Chondrocytes and Expression of Type II Collagen.细胞外核苷酸选择性诱导软骨细胞迁移和 II 型胶原表达。
Int J Mol Sci. 2020 Jul 23;21(15):5227. doi: 10.3390/ijms21155227.
3
Inhibition of P2X7 Purinergic Receptor Ameliorates Cardiac Fibrosis by Suppressing NLRP3/IL-1 Pathway.
JCI Insight. 2023 Mar 22;8(6):e160745. doi: 10.1172/jci.insight.160745.
4
Sex-related differences in the response of anti-platelet drug therapies targeting purinergic signaling pathways in sepsis.在脓毒症中针对嘌呤能信号通路的抗血小板药物治疗的反应存在性别差异。
Front Immunol. 2022 Nov 2;13:1015577. doi: 10.3389/fimmu.2022.1015577. eCollection 2022.
5
Mitophagy: A Potential Target for Pressure Overload-Induced Cardiac Remodelling.自噬:压力超负荷诱导心脏重构的潜在靶点。
Oxid Med Cell Longev. 2022 Sep 27;2022:2849985. doi: 10.1155/2022/2849985. eCollection 2022.
6
Cardiovascular Disease in Duchenne Muscular Dystrophy: Overview and Insight Into Novel Therapeutic Targets.杜氏肌营养不良症中的心血管疾病:概述及对新型治疗靶点的见解
JACC Basic Transl Sci. 2022 Mar 9;7(6):608-625. doi: 10.1016/j.jacbts.2021.11.004. eCollection 2022 Jun.
7
The Interplay of Endothelial P2Y Receptors in Cardiovascular Health: From Vascular Physiology to Pathology.内皮 P2Y 受体在心血管健康中的相互作用:从血管生理学到病理学。
Int J Mol Sci. 2022 May 24;23(11):5883. doi: 10.3390/ijms23115883.
8
Purinergic Signaling in the Regulation of Gout Flare and Resolution.嘌呤能信号在痛风发作和缓解中的调节作用。
Front Immunol. 2021 Dec 1;12:785425. doi: 10.3389/fimmu.2021.785425. eCollection 2021.
P2X7 嘌呤能受体抑制通过抑制 NLRP3/IL-1 通路减轻心脏纤维化。
Oxid Med Cell Longev. 2020 May 21;2020:7956274. doi: 10.1155/2020/7956274. eCollection 2020.
4
Functional heterogeneity of PDGFRα (+) cells in spontaneously active urogenital tissues.自发性活跃的泌尿生殖组织中 PDGFRα(+)细胞的功能异质性。
Neurourol Urodyn. 2020 Aug;39(6):1667-1678. doi: 10.1002/nau.24431. Epub 2020 Jun 12.
5
Higenamine Improves Cardiac and Renal Fibrosis in Rats With Cardiorenal Syndrome via ASK1 Signaling Pathway.辛弗林通过 ASK1 信号通路改善心肾综合征大鼠的心肌和肾脏纤维化。
J Cardiovasc Pharmacol. 2020 Jun;75(6):535-544. doi: 10.1097/FJC.0000000000000822.
6
Purine and purinergic receptors.嘌呤与嘌呤能受体。
Brain Neurosci Adv. 2018 Dec 6;2:2398212818817494. doi: 10.1177/2398212818817494. eCollection 2018 Jan-Dec.
7
A Role for The P2Y1 Receptor in Nonsynaptic Cross-depolarization in the Rat Dorsal Root Ganglia.P2Y1受体在大鼠背根神经节非突触性交叉去极化中的作用
Neuroscience. 2019 Dec 15;423:98-108. doi: 10.1016/j.neuroscience.2019.09.038. Epub 2019 Nov 2.
8
Isorhamnetin Inhibits Liver Fibrosis by Reducing Autophagy and Inhibiting Extracellular Matrix Formation via the TGF-1/Smad3 and TGF-1/p38 MAPK Pathways.山奈酚通过减少自噬和抑制细胞外基质形成来抑制肝纤维化,其作用途径为 TGF-β1/Smad3 和 TGF-β1/p38MAPK。
Mediators Inflamm. 2019 Jul 31;2019:6175091. doi: 10.1155/2019/6175091. eCollection 2019.
9
Inhibition of Mitofusin-2 Promotes Cardiac Fibroblast Activation via the PERK/ATF4 Pathway and Reactive Oxygen Species.抑制线粒体融合蛋白 2 通过 PERK/ATF4 通路和活性氧促进心脏成纤维细胞激活。
Oxid Med Cell Longev. 2019 Apr 16;2019:3649808. doi: 10.1155/2019/3649808. eCollection 2019.
10
The MEK Inhibitor Trametinib Ameliorates Kidney Fibrosis by Suppressing ERK1/2 and mTORC1 Signaling.MEK 抑制剂曲美替尼通过抑制 ERK1/2 和 mTORC1 信号通路改善肾脏纤维化。
J Am Soc Nephrol. 2019 Jan;30(1):33-49. doi: 10.1681/ASN.2018020209. Epub 2018 Dec 10.